IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
about
Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathwayRoquin--a multifunctional regulator of immune homeostasisThe role of suppressors of cytokine signalling in human neoplasmsNon-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43Immunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and InflammationInfection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell responseInhibition of response to alpha interferon by Mycobacterium tuberculosis.HCV immunology--death and the maiden T cell.Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cellsBordetella pertussis infection of primary human monocytes alters HLA-DR expression.Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages.Roles of unphosphorylated STATs in signaling.Bridging the species divide: transgenic mice humanized for type-I interferon response.SOCS proteins in development and disease.Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection.Potential roles of suppressor of cytokine signaling in wound healing.Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.TGFβ1 inhibits IFNγ-mediated microglia activation and protects mDA neurons from IFNγ-driven neurotoxicity.Suppression of the inflammatory response by disease-inducible interleukin-10 gene therapy in a three-dimensional micromass model of the human synovial membraneExpression of interferon alfa signaling components in human alcoholic liver disease.IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis.
P2860
Q24563231-79819A84-5D18-4C1E-AED7-69BC04C24B8AQ26775519-44F73647-17EA-42A2-A803-9016369903A4Q27026783-7A35AA0E-B986-4447-9F27-F9840AA6470CQ27478313-C97FE73E-F16B-4552-9114-898A6A517D66Q27489129-E3F05E4C-9536-467D-B883-5845FB83FE00Q33604750-867025EE-8B4B-4639-9BC0-A7EB6A2662F6Q34681342-89CFFDDC-EBF7-4D32-9567-D7B488CDC750Q34933243-AE0C9E0A-72E5-46AF-8AD4-C7B2C84D8390Q35091469-A49292EA-9491-4C54-B6C1-7E6BBEAE77DBQ35559953-0434C387-43AF-4A90-91C9-766646DE4163Q36576200-5D002A40-3CE1-42BF-8264-2075459A4750Q36645721-E3C49760-7E3E-4B87-9FDE-B92CA6F55A6EQ36990750-DA54125E-BD78-4568-80E8-90BCC465ADBDQ37118445-DE63F2A3-9E3C-4000-BE0D-315E7E0D491BQ37458573-8E4A4EA4-2941-42C9-82E0-3235EF31A7B5Q38124037-F8AA1A31-7085-447E-95C1-195B14112D4AQ38511081-0EA3FA61-490B-467C-9277-8A3B5B5E4D5FQ38733695-7C41F0F1-BD84-4952-BABE-B7ED9667982FQ39450473-F3420D4D-1BA2-44B3-87CB-75FE44649B53Q39539208-C0808061-FBBB-4BFD-9BDE-0F441B1E52D6Q39779359-2BDB014F-92B5-4F47-B819-894E599B26B4Q40119012-D7CF8F2E-03DC-48E9-A4D0-E79C28938649Q41134012-D741B6FE-03F9-4DA1-8CA8-EAC854ED132CQ42360105-2618BDED-BAA4-4902-B641-6D3454E406E3Q43875858-DF5E0F81-27A5-4EEB-A45C-82E1E68891B9Q53871933-E1182DF0-83A2-4B24-92AA-A8DA4694F661
P2860
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
description
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im September 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: September 2000)
@en
vedecký článok (publikovaný 2000/09/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/09/01)
@nl
наукова стаття, опублікована у вересні 2000
@uk
مقالة علمية (نشرت في سبتمبر 2000)
@ar
name
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@ast
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@en
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@nl
type
label
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@ast
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@en
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@nl
prefLabel
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@ast
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@en
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@nl
P2093
P2860
P3181
P1433
P1476
IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3
@en
P2093
P2860
P3181
P356
10.1016/S0014-5793(00)01905-0
P407
P577
2000-09-01T00:00:00Z